133 related articles for article (PubMed ID: 37860331)
1. Retracted: Establishment and Analysis of Hypoxia-Related Model in Oral Squamous Cell Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9898076. PubMed ID: 37860331
[TBL] [Abstract][Full Text] [Related]
2. Retracted: Multiomics Immune-Related lncRNA Analysis of Oral Squamous Cell Carcinoma and Its Correlation with Prognosis.
Markers D
Dis Markers; 2023; 2023():9861260. PubMed ID: 37387768
[TBL] [Abstract][Full Text] [Related]
3. Retracted: Comprehensive and Integrated Analysis Identifies ZEB1 as a Key Novel Gene in Oral Squamous Cell Carcinoma.
Imaging CMM
Contrast Media Mol Imaging; 2023; 2023():9783040. PubMed ID: 37502536
[TBL] [Abstract][Full Text] [Related]
4. Retracted: Biogenic Analysis of the Effect of TERC on Cell Proliferation and Migration of Oral Squamous Cell Carcinoma under Digital Minimally Invasive Treatment.
International BR
Biomed Res Int; 2023; 2023():9798465. PubMed ID: 37388366
[TBL] [Abstract][Full Text] [Related]
5. Retracted: A Novel Immune-Associated Gene Signature for Overall Survival Prediction in Patients with Oral Squamous Cell Carcinoma.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9875478. PubMed ID: 38125198
[TBL] [Abstract][Full Text] [Related]
6. Retracted: LINC01116 Promotes Migration and Invasion of Oral Squamous Cell Carcinoma by Acting as a Competed Endogenous RNA in Regulation of MMP1 Expression.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9847941. PubMed ID: 37811260
[TBL] [Abstract][Full Text] [Related]
7. Retracted: MCU That Is Transcriptionally Regulated by Nrf2 Augments Malignant Biological Behaviors in Oral Squamous Cell Carcinoma Cells.
International BR
Biomed Res Int; 2024; 2024():9840106. PubMed ID: 38230029
[TBL] [Abstract][Full Text] [Related]
8. Retracted: Identification of Differentially Expressed Long Noncoding RNAs as Functional Biomarkers and Construction of Function Enrichment Network in Oral Squamous Cell Carcinoma.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9820845. PubMed ID: 37565232
[TBL] [Abstract][Full Text] [Related]
9. [Retracted] Effect of microRNA-27b on cisplatin chemotherapy sensitivity of oral squamous cell carcinoma via FZD7 signaling pathway.
Liu B; Cao G; Dong Z; Guo T
Oncol Lett; 2024 Jun; 27(6):275. PubMed ID: 38690102
[TBL] [Abstract][Full Text] [Related]
10. Retracted: Implications of Human Antimicrobial Peptide Defensin Beta-1 in Clinical Oral Squamous Cell Carcinoma Patients via an Integrated Bioinformatics Approach.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9820871. PubMed ID: 38094444
[TBL] [Abstract][Full Text] [Related]
11. Retracted: Identification of Novel Biomarkers Related to Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9780526. PubMed ID: 38094439
[TBL] [Abstract][Full Text] [Related]
12. Retracted: BID-Net: An Automated System for Bone Invasion Detection Occurring at Stage T4 in Oral Squamous Carcinoma Using Deep Learning.
Intelligence And Neuroscience C
Comput Intell Neurosci; 2023; 2023():9754061. PubMed ID: 38074376
[TBL] [Abstract][Full Text] [Related]
13. Retracted: Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma.
Markers D
Dis Markers; 2023; 2023():9893453. PubMed ID: 37387739
[TBL] [Abstract][Full Text] [Related]
14. Establishment and Analysis of Hypoxia-Related Model in Oral Squamous Cell Carcinoma.
Lu X; Liu X
J Healthc Eng; 2022; 2022():6602648. PubMed ID: 35432823
[TBL] [Abstract][Full Text] [Related]
15. Retracted: Establishment and External Validation of a Hypoxia-Derived Gene Signature for Robustly Predicting Prognosis and Therapeutic Responses in Glioblastoma Multiforme.
International BR
Biomed Res Int; 2024; 2024():9756795. PubMed ID: 38550039
[TBL] [Abstract][Full Text] [Related]
16. Retracted: Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma.
Markers D
Dis Markers; 2023; 2023():9813418. PubMed ID: 37387737
[TBL] [Abstract][Full Text] [Related]
17. Retracted: IL-32 Promotes the Radiosensitivity of Esophageal Squamous Cell Carcinoma Cell through STAT3 Pathway.
International BR
Biomed Res Int; 2024; 2024():9796319. PubMed ID: 38229987
[TBL] [Abstract][Full Text] [Related]
18. Retracted: Expression of Dickkopf-1 and Twist2 in Cervical Squamous Cell Carcinoma and Their Correlation with Vasculogenic Mimicry.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9817429. PubMed ID: 37621628
[TBL] [Abstract][Full Text] [Related]
19. Retracted: Fibroblast Growth Factor 3 Is Associated with Tongue Squamous Cell Carcinoma: A Controlled Study.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9784949. PubMed ID: 37503431
[TBL] [Abstract][Full Text] [Related]
20. Retracted: An Immune-Related Genetic Feature Depicted the Heterogeneous Nature of Lung Adenocarcinoma and Squamous Cell Carcinoma and Their Distinctive Predicted Drug Responses.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9823238. PubMed ID: 37593686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
